Biolife Solutions Inc (BLFS) — Institutional Holders Breakdown (Q2 2026)

BLFS ranks #2796 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

BLFS is a top-conviction position for Casdin Capital, LLC — at 6.6% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in BLFS belongs to T. Rowe Price Investment Management, Inc., but the position matters far more to Casdin Capital, LLC, who has 6.6% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Penbrook Management LLC has added to its BLFS position for two straight quarters, increasing it by $991.6K to reach $1.4M today.

BLFS posted net income of $58.0M over the trailing twelve months, and currently trades at a P/E of 32.4.

• Profitable — net income of $58.0M over the trailing twelve months
• Revenue declined 30.8% year over year
• Net income improved year over year, from -$5.5M to $58.0M
• Generated $20.1M in positive operating cash flow
• Current ratio of 5.94x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.09x equity — within a conventional range